Acute Electrophysiologic Effects of Nadolol
- 3 February 1983
- journal article
- research article
- Published by Wiley in The Journal of Clinical Pharmacology
- Vol. 23 (2-3) , 93-99
- https://doi.org/10.1002/j.1552-4604.1983.tb02710.x
Abstract
The acute effects of intravenous nadolol (0.01 and 0.02 mg/kg) on cardiac electrophysiologic parameters were assessed with His bundle recording and programmed atrial stimulation. The higher dose of nadolol reduced resting heart rate (71 vs. 65 beats/min, P < 0.02), and the degree of slowing was related to the initial heart rate (r = −0.68, P < 0.05). Atrioventricular conduction time as defined by the paced A—H interval, rose by 12 msec (P < 0.001) after nadolol (0.02 mg/kg) administration. Atrial refractoriness increased (by 10 msec, P < 0.02) only at the higher dose level with nadolol. At both dose levels, atrioventricular nodal effective and functional refractory periods were increased (P < 0.02) by a mean of 45 and 21 msec, respectively, suggesting greater sensitivity of atrioventricular nodal refractoriness to beta‐adrenergic blockade. Nadolol's effects were generally similar to those of previously reported studies with other beta‐adrenergic blockers. These data suggest that nadolol slows conduction through the atrioventricular node and increases atrial and atrioventricular nodal refractoriness.This publication has 24 references indexed in Scilit:
- NadololDrugs, 1980
- Pharmacokinetics of Nadolol, a Beta‐Receptor Antagonist: Administration of Therapeutic Single‐ and Multiple‐Dosage Regimens to Hypertensive PatientsThe Journal of Clinical Pharmacology, 1979
- Long-term treatment of essential hypertension using nadolol and hydrochlorothiazide combined.Published by Wiley ,1979
- Improved physical performance as a therapeutic objective in patients with angina.Published by Wiley ,1979
- Direct Myocardial Depressant Effects of Several -Adrenergic Blocking Agents in the Unanesthetized Atherosclerotic RabbitExperimental Biology and Medicine, 1978
- Comparison of the new beta-adrenoceptor antagonist, nadolol, and propranolol in the treatment of angina pectorisCurrent Medical Research and Opinion, 1978
- Metabolic Studies in Patients with Nadolol: Oral and Intravenous AdministrationThe Journal of Clinical Pharmacology, 1977
- Anti-arrhythmic action of nadolol, a β-adrenergic receptor blocking agentEuropean Journal of Pharmacology, 1976
- Electrophysiology and pharmacology of cardiac arrhythmias IX. Cardiac electrophysiologic effects of beta adrenergic receptor stimulation and blockade. Part CAmerican Heart Journal, 1975
- Pharmacology of nadolol (SQ 11725), a β-adrenergic antagonist lacking direct myocardial depressionEuropean Journal of Pharmacology, 1975